The Department of Defense (DOD) today announced the award of nearly $5 million to 13 innovative and impactful lupus research projects through its new Lupus Research Program.
A recently published study concludes that lupus is among the leading causes of death for women in the U.S.
Announcing a new white paper, "Lupus Community Panel Proposals for Optimizing Clinical Trials: 2018," developed to address critical issues that have stymied the lupus drug development process for decades.
The Omnibus Appropriations bill passed by the US House of Representatives on March 22 includes increased funding for critical lupus research and education programs.
Grantee Spotlight: Tracoyia Roach, 2017 Gina M. Finzi Fellowship Recipient
New datasets provide insight for cells in lupus and RA disease tissue.
Results from a Phase IIb 24-week clinical trial show that Atacicect is safe and may benefit people with high levels of disease activity.
The collaboration between Exagen and GSK will raise awareness of Exagen's AVISE diagnostic and monitoring tests among healthcare professionals around the world.